Navigation Links
Model 1575 Immunowash Microplate Washer

ProductsModel 1575 Immunowash Microplate Washer
Company Bio-Rad Laboratories
Item Model 1575 Immunowash Microplate Washer
Features 
  • Programmable horizontal and vertical needle positions to an accuracy of 0.1 mm for bottom washing, crosswise aspiration, and overflow washing
  • Dispense speed control
  • Plate shaking option to help minimize bubbles and liquid adherence to well sides
  • Waste-bottle sensor to detect high-waste liquid levels
  • Up to 75 programmable washing sequences to customize protocols
  • Easily removable 8- or 12-way manifolds
  • Easily accessible manifold interior for cleaning and maintenance
  • Removable and autoclavable plate carrier
  • Standard aerosol protection cover
  • Integrated vacuum and dispensing pumps to ensure accurate and quiet washing and eliminate the need for bulky and noisy external pumps
Description Bio-Rad's Model 1575 immunowash microplate washer offers complete control of needle position to perform special wash routines and maximize wash efficiency. This system includes a large choice of wash that which facilitate easy wash protocol creation and storage.
Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. Reliance Stool, Model 5346
2. Reliance Stools, Model 5340
3. Reliance Stool, Model 5356
4. Reliance Stool, Model 5348
5. Pachymetric Analyzer Model 55
6. Model 1990 Dermatome
7. The New Model C Dermatome
8. NEW Padgett Model PI - Electro-Dermatome
9. Amo Phaco Model Diplomax
10. KR 4.22 Programmable Refrigerated Floor Model Centrifuge.
11. Model 420 UV Visible Spectrophotometer
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture.
...provide superior tissue excision with precision-ma...pers offer an aggressive tooth pattern to capture ...nique stress pin buffering system to minimize tip ...ffering system applies increasing tension to the i...
Athroscopic leg holder system.
...er-pumps, the REVOLUTION provides continuous flow,...ermore the dual pump system gives the surgeon tota...ate. , ,The REVOLUTION system includes foot pedal ...y to increase flow while maintaining joint pressur...
Medicine Products:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...eration of children developing allergies to foods ...d the University of Michigan Health System to ope...oblem. Fodd allergeyThe new clinic at Dominos Far...nsion of food allergy services previously provided...
...re allaying fears over a tuberculosis outbreak in ...Infant and Junior Schools conducted tuberculosis-s...ee children were found to be infected with the bac...ompletion of the tests, six children were found to...
...d to understand dietary patterns and chronic obstr...that Mediterranean diet halves the chances of dev...D). COPD (chronic obstructive pulmonary disease) ... chronic progressive lung disease, such as emphyse...
... falls for banned substances. The 60-year-old mach...owth hormone Jintropin when he was stopped at Syd...n Australia to promote his film Rocky Balboa, but ...ourt when the confession came to light a couple of...
Other Medicine News:Health News:Minor Tuberculosis Outbreak In Welsh School 2Health News:Sylvester Stallone Admits He Tried to Smuggle Banned Growth Hormone to Australia 2
(Date:10/10/2008)...- TriReme Medical Inc. (TMI),announce...E (Conformite,Europeenne) marking and commercializ... a unique main vessel stent system specially desig...presenting the next generation in bifurcation sten...a quarter of the 2.2 million,angioplasty procedure...
(Date:10/9/2008)...ected in November 2008, BOTHELL, Wash., Oct. 9 /P... DDD ) announced today the completion of patient e...votal trials to evaluate the safety and,efficacy o... ibuprofen for,the over-the-counter (OTC) market. ...m this pivotal trial in November 2008. Ibuprofen i...
(Date:10/8/2008)... Use in Cosmetics and Chemicals Testing, ASHLAND,...announced,that results of a recently completed US ...n study on MatTek,s EpiDerm in vitro human skin ti... required sensitivity and,specificity for EpiDerm ...l,testing for determining human skin irritation by...
(Date:10/8/2008)...entists Expand Testing Using Cellular ...aine, Oct. 8 /- Wild Blueberry antiox...results from a new study,showing Wild Blueberries ...s like apples, bananas, red grapes and strawberrie...nt Activity (CAA) assay. New research,published in...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Treatment blocks pain without disrupting other functions 1036 1Treatment blocks pain without disrupting other functions 1036 2Treatment blocks pain without disrupting other functions 1036 3California State PTA Issues Statement Regarding Presidents Veto of SCHIP Legislation 2831 1Billions Directed to Baghdad Millions Rejected for Children 2826 1Solazyme Announces New Senior Vice President of Business Development 1033 1Solazyme Announces New Senior Vice President of Business Development 1033 2
...t Generation Renin Inhibitor to Continue Phase II ...and and BRIDGEWATER NJ/USA, 28 June 2007-Speedel,(...ther significant,milestone in the development of i...completion of a Phase IIa proof-of-concept clinica...ion. Based on these,positive results, the company ...
...KHAM, ON, June 28, 2007 /PRNewswire/ - Cytochroma ...clinical trial of,CTA018 Injection. The initial to...was safe and well tolerated. Complete study,result...leted Phase I trial was an open label,placebo-con...nistered to 20 healthy volunteers. In this trial, ...
Other Medicine Technology:Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 2Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 3Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 4Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 5Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 6Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 7Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 8Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3